Greg Abel Sells Berkshire Hathaway Stocks Managed by Former Investment Manager Todd Combs 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
Nidec Stock Rises After Accounting Probe Report Eases Delisting Concerns 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Tesla Q1 Earnings Preview: Robotaxi Delays and SpaceX Merger Speculation Grow 
J.P. Morgan Downgrades Essity AB on Rising Costs and Weak Earnings Outlook 
Indian Refiners Use Yuan via ICICI Bank to Pay for Iranian Oil Under U.S. Sanctions Waiver 
Eli Lilly in Talks to Acquire Kelonia Therapeutics for Over $2 Billion 
AEVEX Raises $320 Million in IPO Amid Surging Defense Sector Demand 
How Technology Is Reshaping Modern Business: From Operations to Customer Experience 
Anthropic CEO Meets Trump Officials to Discuss Powerful New AI Model Mythos 
Tesla's Terafab: AI Chip Factory Eyes Taiwan's Semiconductor Talent 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
SK Hynix Launches 192GB SOCAMM2 Memory for Nvidia’s Next-Gen AI Chips 
Chinese Robotics Stocks React as Humanoid Robot Marathon Sparks Competition Concerns 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Daikin Industries Stock Surges 14% After Elliott Investment Management Discloses Major Stake 
ALBANY, N.Y., March 29, 2016 -- AngioDynamics (NASDAQ:ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, surgery, peripheral vascular disease and oncology, today announced it will report financial results for its fiscal 2016 third quarter ended February 29, 2016, on Thursday, April 7, 2016, after the close of the U.S. financial markets.
Management will host a conference call beginning at 4:30 p.m. ET on April 7, to discuss the results and to answer questions. To participate in the live call by telephone, please call 800-533-7619 and reference the Conference ID: 3916864.
A live webcast and subsequent archived replay of the conference call may be accessed via the investor relations section of the Company's website under "Events & Presentations" at investors.angiodynamics.com/events. To listen to the live webcast, please go to the website 15-minutes prior to its start to register, download and install the necessary audio software.
About AngioDynamics
AngioDynamics Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, surgery, peripheral vascular disease and oncology. AngioDynamics' diverse product lines include market-leading ablation systems, fluid management systems, vascular access products, angiographic products and accessories, angioplasty products, drainage products, thrombolytic products and venous products. More information is available at AngioDynamics.com.
Trademarks
AngioDynamics and the AngioDynamics logo are trademarks and/or registered trademarks of AngioDynamics Inc., an affiliate or a subsidiary.
Company Contact: AngioDynamics Inc. Caitlin Stefanik (518) 795-1418 [email protected] Investor Relations Contacts: FTI Consulting Jim Polson (312) 553-6730 [email protected] Media Contact: FTI Consulting Kimberly Ha (212) 850-5612 [email protected]
